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blaNDM genes confer carbapenem resistance and have been identified on transferable plasmids belonging to different incompati-
bility (Inc) groups. Here we present the complete sequences of four plasmids carrying a blaNDM gene, pKP1-NDM-1, pEC2-
NDM-3, pECL3-NDM-1, and pEC4-NDM-6, from four clinical samples originating from four different patients. Different plas-
mids carry segments that align to different parts of the blaNDM region found on Acinetobacter plasmids. pKP1-NDM-1 and
pEC2-NDM-3, from Klebsiella pneumoniae and Escherichia coli, respectively, were identified as type 1 IncA/C2 plasmids with
almost identical backbones. Different regions carrying blaNDM are inserted in different locations in the antibiotic resistance is-
land known as ARI-A, and ISCR1may have been involved in the acquisition of blaNDM-3 by pEC2-NDM-3. pECL3-NDM-1 and
pEC4-NDM-6, from Enterobacter cloacae and E. coli, respectively, have similar IncFIIY backbones, but different regions carrying
blaNDM are found in different locations. Tn3-derived inverted-repeat transposable elements (TIME) appear to have been in-
volved in the acquisition of blaNDM-6 by pEC4-NDM-6 and the rmtC 16S rRNAmethylase gene by IncFIIY plasmids. Character-
ization of these plasmids further demonstrates that even very closely related plasmids may have acquired blaNDM genes by differ-
ent mechanisms. These findings also illustrate the complex relationships between antimicrobial resistance genes, transposable
elements, and plasmids and provide insights into the possible routes for transmission of blaNDM genes among species of the En-
terobacteriaceae family.
InGram-negative bacteria, especially the Enterobacteriaceae fam-ily, -lactamases are the major mechanism of resistance against
-lactams. In particular, -lactamases known as carbapenemases
are becoming a key concern in the effective administration of an-
timicrobial therapy, as they can confer resistance to carbapenems,
a major last-line antimicrobial. The NDM carbapenemase was
first reported in 2009, produced by a Klebsiella pneumoniae iso-
lated from a Swedish patient recently returned from India (1).
There are currently 16 known NDM variants, and blaNDM genes
have now been reported in strains sourced from every inhabitable
continent and in multiple species of Enterobacteriaceae, including
Escherichia coli, K. pneumoniae, and Enterobacter cloacae (2).
Plasmids are important vehicles for the capture, accumulation,
and spread of various antimicrobial resistance determinants. Sev-
eral different types of plasmids associated with the Enterobacteri-
aceae family have been reported to harbor blaNDM genes, includ-
ing IncA/C, IncFII subtypes, IncH types, IncL/M, IncN (2–4), and
IncX (5). Some of these plasmids coharbor additional antimicro-
bial resistance genes, including the 16S rRNA methylase genes
armA and rmtC (conferring high-level aminoglycoside resis-
tance), quinolone resistance genes (qnrB1 and qnrS1), and/or
other -lactamase genes (such as blaCMY-2 and variants and
blaCTX-M-15) (6).
The original source of blaNDM is not known, but Acinetobacter
spp.may have acted as an intermediate between this organism and
the Enterobacteriaceae family (7–9). In Acinetobacter spp., blaNDM
genes have often been observed within the 10,099-bp composite
transposon Tn125 that is bounded by two copies of ISAba125
(9–12). The blaNDM gene starts 93 bp downstream of the right-
hand end (IRR) of ISAba125, which provides the35 region of a
promoter (13, 14), and is followed by several genes, including
bleMBL (bleomycin resistance), trpF (involved in tryptophan bio-
synthesis), and the mobile element ISCR27. In several Acinetobac-
ter species plasmids (e.g., pNDM-BJ01; GenBank accession no.
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NC_019268 [15]), ISAba14 and an aphA6 gene (amikacin resis-
tance) are present upstream of the ISAba125 adjacent to blaNDM-1
(Fig. 1A). In plasmids from the Enterobacteriaceae, blaNDM genes
are generally found in this immediate genetic context, with at least
a fragment of ISAba125 containing the35 promoter region pres-
ent upstream, within different length fragments matching Acin-
etobacter plasmids and associated with different mobile elements
(3, 16–21).
We previously reported locally identified K. pneumoniae (22)
and E. cloacae (23) clinical isolates carrying blaNDM-1, E. coli car-
rying blaNDM-3 (G283A, Asp95Asn) (23), and E. coli carrying
blaNDM-6 (C698T, Ala233Val) (24). The blaNDM gene could be
transferred from all four isolates by transformation and/or conju-
gation, indicating a plasmid location in each case, but replicon
types were not determined (22–24). In this study, we present the
complete sequences of these four plasmids and a comparison of
the genetic contexts of blaNDM with those in closely related plas-
mids.
MATERIALS AND METHODS
Bacterial isolates and plasmids. K. pneumoniae KP1 (22) and E. cloacae
ECL3 carrying blaNDM-1 (23) were isolated in Australia, as was E. coli EC2
carrying blaNDM-3 (23), while E. coli EC4 carrying blaNDM-6 (previously
designated ARL10/167 [24]) was isolated in New Zealand. All isolates
were from patients recently returned from India. Transconjugants in so-
diumazide-resistantE. coli J53Azir were available and/orwere obtained by
conjugation on solid medium, as previously described (17).
DNA preparation and sequencing. Genomic DNA (gDNA) was ex-
tracted from all four isolates using the UltraClean Microbial DNA isola-
tion kit (Mo Bio Laboratories, Inc., Carlsbad, CA, USA). DNA from KP1,
ECL3, and EC4 was sequenced by Illumina HiSeq 2000 technology (Illu-
mina, San Diego, CA, USA). Illumina sequences were de novo assembled
using CLC genomic workbench v8.0 (CLCBio, Aarhus, Denmark). Initial
FIG 1 ARI-A of type 1 IncA/C2 plasmids carrying blaNDM and potential routes for blaNDM insertion. IS are shown as block arrows labeled with their name or
number. DR are represented by flags of the same color. Triangles indicate the insertion sites of IS elements flanked by DR. Vertical black bars represent the
transposon IR of ARI-A and IRi of class 1 In/Tn. Horizontal green and black lines represent Acinetobacter and IncA/C2 plasmid backbones, respectively. Vertical
dotted lines indicate the boundaries of closely related sequences. Vertical black arrows and dotted diagonal lines indicate possible deletion and insertion events.
(A) Tn125 in Acinetobacter lwoffii plasmid pNDM-BJ01. (B) ARI-A of type 1 IncA/C2 plasmids closely related to pKP1-NDM-1 and pEC2-NDM-3. (C) Possible
derivation of the circular molecule inserted in pEC2-NDM-3. (D) Insertion of circular molecule carrying blaNDM into pEC2-NDM-3 and a P. mirabilis genomic
island. The sequences used to draw these diagrams are from the GenBank accession numbers listed in Table 1 plus the following: pNDM-BJ01, NC_019268;
pSAL-1, AJ237702; pKP048, NC_014312; SGI1-V, HQ888851; PGI1-PmPEL, KF856624.
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annotation of contigs was performed using RAST (25). IS finder (https:
//www-is.biotoul.fr/) and the Repository of Antibiotic-resistance Cas-
settes (RAC; http://rac.aihi.mq.edu.au/rac/) were used to identify inser-
tion elements (IS) and integron components, respectively. BLAST (http:
//blast.ncbi.nlm.nih.gov/Blast.cgi) searches were used to identify related
plasmids carrying blaNDM to guide PCR-based gap closure and Sanger se-
quencing (Macrogen, South Korea) to assemble contigs into complete plas-
mids.
gDNA fromEC2was sheared using a g-TUBE (Covaris) into fragment
sizes targeted at 20 kb. Following purification, SMRTbell template librar-
ies were prepared using the commercial Template Preparation kit (Pacific
Biosciences Inc., Menlo Park, CA, USA) and sequenced on a Pacific Bio-
sciences (PacBio) RSII instrument (University of Queensland Centre for
Clinical Genomics [UQCCG]) using the P6 polymerase and C4 sequenc-
ing chemistry. The raw PacBio sequence data were assembled de novo
using the hierarchical genome assembly process (HGAP version 2) and
Quiver (26) from the SMRT Analysis software suite (version 2.3.0;
PacBio) with default parameters and a seed read cutoff of 17,000 bp.
Following assembly, contigs were examined for overlapping 5= and 3=
ends (a characteristic feature of the HGAP assembly process) using Con-
tiguity (27) and were manually trimmed to generate circular contigs. Raw
sequence reads were then mapped back onto the assembled circular plas-
mid contig (BLASR [28] and Quiver) to validate the assembly and resolve
any remaining errors.
RAST, IS finder, RAC,CLCgenomicworkbench v8.0, GeneiousR9 (Bio-
matters Ltd.,NewZealand, includingMauve [29]), andBLASTwere used for
manual annotation, alignment, single nucleotide polymorphism (SNP) de-
tection, and other analysis and comparisons of complete plasmid sequences.
Nucleotide sequence accession numbers. Existing GenBank entries
for partial sequences of all four plasmids were updated to include the
complete sequences, as follows: pKP1-NDM-1, KF992018; pEC2-
NDM-3, KC999035; pECL3-NDM-1, KC887917; pEC4-NDM-6,
KC887916.
RESULTS AND DISCUSSION
General features of plasmids carrying blaNDM. Isolates KP1, EC2,
ECL3, and EC4 each transferred a plasmid carrying blaNDM to E. coli
J53Azir by conjugation. Plasmids carrying blaNDM assembled from
whole-genome sequences (at least 50-fold coverage) were desig-
nated pKP1-NDM-1, pEC2-NDM-3, pECL3-NDM-1, and pEC4-
NDM-6, respectively. pKP1-NDM-1 (137,552 bp) and pEC2-
NDM-3 (160,989 bp) were identified as type 1 IncA/C2 (Table 1).
The backbones of pKP1-NDM-1 and pEC2-NDM-3 are very closely
related to those of several other type 1 IncA/C2plasmids (seeTable S1
in the supplementalmaterial) and includecharacteristic IncA/C2core
regions, such as the conjugative transfer (tra) region and parA-parB,
required for plasmid partitioning (30). They have identical replica-
tion regions, with a repA gene and 14 19-bp direct repeat sequences
(iterons), which are binding sites for the RepA protein (30). Both
pKP1-NDM-1 and pEC2-NDM-3 have the same ISEcp1 transposi-
tion unit carrying a blaCMY-2 variant, in this case blaCMY-6, inserted in
the same location as inmanyother type 1 IncA/C2 plasmids, between
traA and traC, flanked by 5-bp direct repeats (DR). Neither carries
Tn6170, present in some type 1 IncA/C2 plasmids (31).
Both pECL3-NDM-1 (99,435 bp) and pEC4-NDM-6 (110,786
bp) are IncFIIY type plasmids (Table 1) carrying two replicons,
classified as Y4 (repA) and FIB36 (repB) by the replicon sequence
typing (RST) scheme (32). The backbones of both plasmids are
closely related to those of other IncFIIY plasmids carrying blaNDM
(Table 1), which have not been well studied but include a conju-
gation (tra) region and stability (psi, parAB) and maintenance
(ccdAB) genes (18, 19).
Both IncA/C2 plasmids carry blaNDM in antibiotic resistance
island ARI-A. In both IncA/C2 plasmids sequenced here, the
TABLE 1 General features of IncA/C2 and IncFIIY plasmids studied here and close relatives
a




pKP1-NDM-1 1 137,552 K. pneumoniae 147 India/Australia 2010 Human KF992018 This study
pEC2-NDM-3 3 160,989 E. coli 443 India/Australia 2010 Human KC999035 This study
pNDM-EcoGN568 1 166,750 E. coli 1289 India/Canada na Human KJ802404 50
pNDM-PstGN576 1 147,886 P. stuartii N/A India/Canada na Human KJ802405 50
pNDM102337 1 165,974 E. coli na Canada na na NC_019045
pNDM10505 1 166,744 E. coli na Canada na na NC_019069
pNDM10469 1 137,813 K. pneumoniae na Canada na na NC_019158
pNDM-KN 1 162,746 K. pneumoniae 14 Kenya 2009 Human JN157804 51, 52
pNDM-US 1 140,825 K. pneumoniae 11 India/USA 2010 Human CP006661 53
pNDM-US-2 1 140,821 K. pneumoniae na KJ588779c
FIIY
pECL3-NDM-1 1 99,435 E. cloacae 265 India/Australia 2011 Human KC887917 This study
pEC4-NDM-6 6 110,786 E. coli 101 India/New
Zealand
2010 Human KC887916 This study
pKOX_NDM1 1 110,781 Klebsiella oxytoca na China/Taiwan 2010 Human NC_021501 18
pNDM1_EC14653 1 109,353 E. cloacae 177 China 2014 Human KP868647 43
pNDM-EclGN574 1 110,786 E. cloacae na India/Canada na Human KJ812998 50
pP10164-NDM 1 99,276 Leclercia adecarboxylata N/A China 2012 Human KP900016 19
pRJF866 1 110,786 K. pneumoniae 11 China 2011 Human NC_025184 54
pK351 1 106,844 K. pneumoniae 147 Iran/USA 2014 Human KR351290 41
a Plasmids with names in bold typeface were sequenced in this study. Abbreviations: na, not available; N/A, not applicable (no multilocus typing schemes for these species); ST,
sequence type.
b Travel history is given if available, e.g., India/Australia indicates isolation in Australia from a patient recently returned from India.
c GenBank accession no. KJ588779 implies that pNDM-US-2 was extracted in China from the same strain (ATCC BAA-2146) as pNDM-US.
Wailan et al.
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blaNDM gene is located within an antibiotic resistance island
known as ARI-A, which is found in exactly the same location in
different type 1 IncA/C2 plasmids, between two tra regions (30,
31). The prototype ARI-A, found in pRMH760, is a complex hy-
brid transposon structure bounded by 38-bp inverted repeats (IR)
interrupted by IS4321 and is inserted upstream of the rhs gene
(unknown function) flanked by 5-bp DR (TTGTA) (31, 33).
ARI-A in pRMH760 carries a class 1 In/Tn, with IS26-aphA1-IS26
interrupting the Tn402 tni region, and other resistance genes. Is-
lands carrying blaNDM appear to be derived from this structure,
with deletions of part of the adjacent rhs gene in some cases (3). In
pNDM102337 (Table 1; Fig. 1B), nucleotides 1 to 1,617 of the
3=-conserved segment (3=-CS) of the class 1 integron are followed
by a 3,562-bp region carrying a type III restriction-modification
system and the rmtC 16S rRNAmethylase gene and then 224 bp of
the IRR end of ISEcp1. ISEcp1 is truncated by ISKpn14, which is
followed by a 198-bp fragment of ISAba14 and then a region
found on a number of different plasmids that contains the aac(3)-
IId (gentamicin resistance) gene and ISCfr1 (34). The adjacent
fragment of the Tn402 tni region has the same boundary with IS26
as in ARI-A of pRMH760, but only 217 bp of IS26 is present. This
is followed by an 8,913-bp region matching Acinetobacter plas-
mids such as pNDM-BJ01, which includes 662 bp of the right end
of ISAba14, aphA6, one copy of ISAba125, blaNDM-1, and a frag-
ment of ISCR27.
pNDM10505, pNDM-PstGN576, and pNDM-EcoGN568
(Table 1) have a variant of the pNDM102337 ARI-Awith a second
ISKpn14 inserted 130 bpupstreamof the left end of ISAba125 (Fig.
1B). ISKpn14-mediated deletion may have been responsible for
creating the ARI-A variant present in the other closely related type
1 IncA/C2 plasmids pNDM-US, pNDM-US-2, pNDM-KN, and
pNDM10469, which lack the aac(3)-IId region (Table 1; Fig. 1B)
(3). pKP1-NDM-1, sequenced here, has an almost identical
ARI-A, except that only 89 bp of ISAba125 is present adjacent to
ISKpn14 upstream of blaNDM. This difference was confirmed by
reexamining raw reads and has been seen in other partial se-
quences (17, 35), and ISKpn14 is89% identical to IS1, which is
known to cause adjacent deletions (34). All of these type 1 IncA/C2
plasmids except pNDM-KN have the same cassette array, consist-
ing of a single fused cassette comprised of the first 87 bp of the
blaOXA-30 cassette and position 17 to the end of the aacA4 cassette,
overlapping by a single A (36). The mechanism(s) responsible for
insertion of the blaNDM region into the proposed pNDM102337-
like progenitor plasmid is unclear, but it is possible that it involved
ISCR27 and/or IS26 and subsequent deletion(s).
The backbone of pEC2-NDM-3 is almost identical to the
pNDM102337-like plasmids described above (see Table S1 in the
supplemental material), but ISEc23 is inserted 222 bp upstream of
ARI-A, flanked by 8-bp DR characteristic of this element. ARI-A
of pEC2-NDM-3 includes the same rmtC region as the one de-
scribed above except that IS3000 is inserted upstream of rmtC,
flanked by characteristic 5-bp DR. The region containing blaNDM,
however, is different from the one in the other IncA/C2 plasmids
and is inserted between ISKpn14 and the aac(3)-IId/ISCfr1/tni402
region. The regionmatching pNDM-BJ01 encompasses 198 bp of
ISAba14, aphA6, one copy of ISAba125, blaNDM, bleMBL, and trpF.
ISKpn25, carrying a restriction-modification system, is inserted in
ISAba125 upstream of the35 promoter region, flanked by char-
acteristic 8-bp DR (Fig. 1B). The blaNDM gene has the single nu-
cleotide change giving blaNDM-3 rather than blaNDM-1, and trpF is
followed by a truncated blaDHA gene and the associated ampR
gene, nucleotides 180 to 1,313 of the 3=-CS and ISCR1. This region
is separated from a complete ISAba14 by 934 bp matching the
region upstream of ISAba14 in pNDM-BJ01. ARI-A in pEC2-
NDM-3 ends with the aac(3)-IId-ISCfr1-tni402 region, but a com-
plete copy of IS26 truncates the rhs gene in the IncA/C2 backbone.
The only other known location of the blaNDM-3 variant is on an
IncFII plasmid (37) associated with ISCR1 but not with the trun-
cated blaDHA-ampR region present in pEC2-NDM-3.
This context in pEC2-NDM-3 suggests insertion of blaNDM
froma circularmoleculemediated by ISCR1. ISCR1 is proposed to
transpose by a rolling-circle mechanism, similar to the related
IS91 family elements (38), in which replication proceeds from the
oriIS end, located downstream of rcr (rolling-circle replicase
gene), toward the terIS upstream and can continue into and cap-
ture an adjacent region. ISCR1 has generally been found associ-
ated with class 1 integrons, after position 1,313 of the 3=-CS, sug-
gesting integration of circular molecules by recombination in
either the 3=-CS or an existing ISCR1 (38). ISCR1 has previously
been suggested to be associated with movement of blaNDM (39)
and was recently shown to be responsible for mobilizing a region
containing blaNDM and part of the 3=-CS, but without the
blaDHA-ampR region, between plasmids (20).
ISCR1 appears to have been responsible for capturing the
blaDHA-ampR region from the Morganella morganii chromo-
some and inserting it into a class 1 integron (40) (Fig. 1C). Gen-
eration of a circular molecule by recombination between the two
flanking 3=-CS and reintegration at ISCR1 could create the ar-
rangement seen in, e.g., pKP048 (GenBank accession no.
NC_014312), with ISCR1 downstream of the blaDHA-ampR re-
gion and the 3=-CS, and the usual 3=-CS/ISCR1 boundary (Fig.
1C). ISCR1 may then have mobilized this 3=-CS segment and the
blaDHA-ampR region and inserted them downstream of blaNDM,
before picking up the blaNDM region as part of a circular molecule
(Fig. 1C).
The complete ISAba14 in pEC2-NDM-3 has the same bound-
ary with the aac(3)-IId region as the ISAba14 fragment in
pNDM102337, suggesting that homologous recombination be-
tween the complete and partial copies of ISAba14 could have been
responsible for the insertion of this circular molecule into pEC2-
NDM-3 (Fig. 1D). The same circular molecule carrying blaNDM
also appears to have inserted in a Proteus mirabilis genomic island
to create PGI-PmPEL (39) but in this case by recombination in
ISCR1 (Fig. 1D), supporting the proposed mechanism of ISCR1-
mediated capture of blaNDM. Regions containing the same ISCR1,
3=-CS, blaDHA-ampR region, but adjacent to shorter fragments
of the blaNDM region, are found in the original blaNDM-1 plasmid
pKpANDM-1 (FN396876.1) (1) and in plasmids of other Inc
types (3) (e.g., the IncL/M plasmid pNDM-HK) (21), suggesting
capture of shorter blaNDM regions and/or subsequent deletions.
IncFIIY plasmids carry blaNDM flanked by TIMEs. Several
very closely related IncFIIY plasmids carrying a blaNDM gene have
nowbeen identified (Table 1). They all have almost identical back-
bones with the same insertions ofmultiple IS elements in the same
places, mostly between the replication (repA) and plasmid stabil-
ity (parA) regions (Fig. 2) and minor sequence differences (see
Table S2 in the supplemental material). pKP351 alone appears to
have a deletion adjacent to one copy of IS1 (41). In all of these
plasmids, blaNDM lies within a 5,945-bp region matching Tn125
that includes 101 bp of ISAba125 and a fragment of ISCR27. This
blaNDM Acquisition by IncA/C2 and IncFIIY Plasmids
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region is flanked by two copies of a 256-bp Tn3-derived inverted-
repeat transposable element (TIME), each bounded by 38-bp IRs
(42). These TIMEs, previously described as miniature inverted-
repeat transposable elements (MITEs),may have been responsible
for capturing the blaNDM region from a pNDM-BJ01-like plasmid
(18, 19, 43). pEC4-NDM-6 is very closely related to these plasmids
(see Table S2 in the supplemental material) but has the single
nucleotide change giving blaNDM-6 (44) rather than blaNDM-1, sug-
gesting mutation in this context.
In most of these IncFIIY plasmids carrying blaNDM, an
11,029-bp region that includes the rmtC gene and an ISCR6-like
element separates the TIME upstream of blaNDM-1 from a third
copy of this TIME. TIMEs create a 5- to 6-bp DR on transposition
like the Tn3 transposons from which they appear to be derived
(42). In these plasmids, the 5-bp sequences adjacent to the “in-
side” of each TIME flanking the rmtC region are identical (TAT
AA). This configuration could be explained by insertion of a cir-
cular molecule, consisting of this region plus one copy of the
TIME (flanked by these 5-bp sequences as DR), into the TIME
upstream of blaNDM-1 (Fig. 2B). Gain and loss of the rmtC region
in this way are supported by the sequences of the IncFIIY plasmids
pP10164-NDM and pNDM-EC14653 (Table 1; Fig. 2B), which
lack the rmtC region. Removing the TIME and one DR from this
circular molecule also gives a region that matches the rmtC region
found in ARI-A of IncA/C2 plasmids, also supporting this hypoth-
esis. rmtC was originally identified in a transposition unit flanked
by a DR with a complete copy of ISEcp1 that also matches part of
this structure (Fig. 2C) (45). The same 30 bp separate rmtC from
this complete ISEcp1 and the ISEcp1 fragment in IncA/C2 plas-
mids, while an additional 10 bp are present between ISCR6 and
rmtC. While these contexts are clearly related, without additional
examples of rmtC contexts it is difficult to say exactly how each
arose.
pECL3-NDM-1 carries the same rmtC region as the other
IncFIIY plasmids, but its backbone has a number of confirmed
nucleotide differences (see Table S2 in the supplemental material)
and a different region carrying blaNDM-1 has been inserted in a
different location (Fig. 2B). This region matches pNDM-BJ02,
which lacks the copy of ISAba125 downstream of blaNDM (3),
rather than pNDM-BJ01, and also includes 1,369 bp of pNDM-
BJ02 backbone. An IS903-like element truncates ISAba125, leav-
ing 83 bp upstream of blaNDM-1. This 10,411-bp region replaces a
15,560-bp region present in the other IncFIIY plasmids, and it is
possible that the IS903-like element was involved in the insertion
of this blaNDM region into pECL3-NDM-1.
Conclusions. In summary, the analysis presented in this study
supplements and complements the catalogue of previously char-
acterized IncA/C2 and IncFIIY plasmids carrying blaNDM. All four
plasmids studied here carry segments that align to different parts
of the blaNDM regions found on Acinetobacter plasmids. Different
mechanisms appear to have been responsible for independently
transferring different segments of Tn125 into ARI-A in the same
IncA/C2 plasmid backbone (giving pKP1-NDM-1-type plasmids
or pEC2-NDM-3). Other less closely related type 1 IncA/C2 plas-
mids, e.g., pNDM-1_Dok01 from E. coli (46) and pMR0211 from
Providencia stuartii (47), also carry segments matching different
FIG 2 Contexts of blaNDM on IncFIIY plasmids. Features are generally shown as described for Fig. 1. Solid black lines represent the IncFIIY plasmid backbone.
Gray-shaded areas indicate matching plasmid backbone regions, with their sizes given. (A) Tn125 inAcinetobacter lwoffii plasmid pNDM-BJ01. (B) Comparison
of IncFIIY plasmids. (C) Comparison of rmtC contexts in IncFIIY, plasmids, IncA/C2 ARI-A, and Proteus mirabilis. The sequence shown is the spacer between
rmtC and the associated transposable element. The pink triangle indicates the insertion site of the TIME. The sequences used to draw these diagrams are from the
GenBank accession numbers listed inTable 1 plus the following: pNDM-BJ01,NC_019268; pNDM-BJ02,NC_019281.1; ISEcp1 transposition unit inP.mirabilis,
AB194779.
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parts of Tn125 and the adjacent Acinetobacter plasmid backbone
within ARI-A, illustrating further variation in the ways in which
blaNDM genes appear to have been acquired by similar plasmids.
Different mechanisms also appear to have transferred different
segments matching blaNDM contexts found in Acinetobacter bau-
mannii to slightly different IncFIIY backbones (giving pEC4-
NDM-1-type plasmids or pECL3-NDM-1).
At least theoretically, the transfer of blaNDM segments between
Acinetobacter and Enterobacteriaceae plasmids could have oc-
curred either in Acinetobacter or in one or more of the Enterobac-
teriaceae. Transfer of Acinetobacter plasmids carrying blaNDM into
E. coli J53Azr by conjugation has been demonstrated (12, 13), and
recently a pNDM-BJ01-like plasmid (p3SP-NDM) was found in
an Enterobacter aerogenes isolate (48). IncA/C plasmids have also
been reported in a fewA. baumannii clinical isolates on the basis of
PCR assays (49). While independent transfer from Acinetobacter
plasmids to different types of plasmids found in the Enterobacte-
riaceae is possible, it may be more likely that blaNDM regions have
subsequently moved between these plasmids in the Enterobacteri-
aceae.
The four plasmids in this study were carried by clinical isolates
from Australia or New Zealand, from different patients recently
returning from India. We have also recently reported partial se-
quences of blaNDM contexts matching pKP1-NDM-1 (with the
89-bp ISAba125 fragment) in IncA/C plasmids harbored by iso-
lates from a hospital in Pakistan (17) and those matching pECL3-
NDM-1 or pEC4-NDM-6 in IncFIIY plasmids in isolates from
multiple Australian health care facilities (16). The other related
IncA/C2 and IncFIIY plasmids harboring blaNDM genes discussed
here were also isolated in several different countries (Table 1).
This distribution illustrates the geographical spread of blaNDM
genes on these particular plasmid types.
There appears to be an underlying complex network of inter-
actions between blaNDM, different mobile elements, and different
plasmids, but without access to the sequences of additional inter-
mediate and progenitor plasmids it is difficult to fully understand
the contributions that different factors make to the transmission
of blaNDM genes. The different mechanisms observed here to cap-
ture relevant genes onto different plasmid types emphasize the
capability of Enterobacteriaceae to adapt to their environment,
especially when antimicrobial pressure is present.
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